EPIM
GILD icon

Evelyn Partners Investment Management’s Gilead Sciences GILD Stock Holding History

Evelyn Partners Investment Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$107K Hold
766
– – ﹤0.01% 243
2025
Q4 		$94K Hold
766
– – ﹤0.01% 247
2025
Q3 		$85K Hold
766
– – ﹤0.01% 251
2025
Q2 		$84.9K Hold
766
– – ﹤0.01% 247
2025
Q1 		$85.8K Hold
766
– – ﹤0.01% 245
2024
Q4 		$70.8K Buy
+766
New +$69K ﹤0.01% 258

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Evelyn Partners Investment Management's GILD Position: Q1 2026 in Review

Evelyn Partners Investment Management held its Gilead Sciences (GILD) position steady in Q1 2026 at 766 shares worth $107K. The position accounts for ﹤0.01% of the portfolio, ranked #243.

Evelyn Partners Investment Management first reported a position in GILD in Q4 2024 and has held it in 6 quarters since. 2,314 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Evelyn Partners Investment Management held 766 shares of Gilead Sciences worth $107K as of Q1 2026.
  • Evelyn Partners Investment Management left its Gilead Sciences share count unchanged in Q1 2026.
  • Gilead Sciences made up ﹤0.01% of Evelyn Partners Investment Management's portfolio in Q1 2026, its #243 holding.
  • Evelyn Partners Investment Management first reported a position in Gilead Sciences in Q4 2024 and has held it in 6 quarters since.
  • 2,314 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Evelyn Partners Investment Management's 13F filing for Q1 2026, filed 15 May 2026.